ADMA Biologics Inc (ADMA) Social Stream



ADMA Biologics Inc (ADMA): $3.32

0.08 (+2.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ADMA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

ADMA BIOLOGICS INC (ADMA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ADMA BIOLOGICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 5 $10 $3 $5.7 $3.24 75.93%
2021-11-11 5 $10 $3 $5.7 $3.24 75.93%
2022-01-06 4 $10.001 $3 $5.7 $3.24 75.93%
2022-03-24 4 $8 $3 $5.3 $3.24 63.58%
2022-03-28 3 $8 $3 $5.3 $3.24 63.58%
2022-05-12 2 $6 $3 $4.625 $3.24 42.75%
2022-07-25 3 $5 $4 $4.5 $3.24 38.89%
2022-08-11 3 $5 $4 $4.666 $3.24 44.01%
2022-10-13 4 $5 $4 $4.75 $3.24 46.6%
2022-11-11 3 $6 $4 $5 $3.24 54.32%

The Trend in the Analyst Price Target


Over the past 12 months, ADMA's average price target has gone down $0.7.

Over the past 44 weeks, ADMA's average upside potential has been 157.34%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-06 4 10.001 3 5.7 1.31 335.11%
2022-03-28 3 8.000 3 5.3 1.76 201.14%
2022-07-25 3 5.000 4 4.5 2.19 105.48%
2022-11-11 4 6.000 4 5.0 3.27 52.91%
2022-11-11 3 6.000 4 5.0 3.27 52.91%

ADMA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 31 months, ADMA's average broker recommendation rating improved by 0.43.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how ADMA BIOLOGICS INC fares relative to all US stocks, note that its average analyst price target is higher than 36.92% of that group.
  • In terms of how ADMA BIOLOGICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 134.1% of that group.
  • In terms of how ADMA BIOLOGICS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -394.33% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ADMA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is higher than 257.98% of them.

Stocks similar to ADMA BIOLOGICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTE, VXRT, and PSTX.

Is ADMA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6496 seconds.